HypaHub, Inc.
where everyone can be a data scientist
Est 2019|Raised $500K
Published Jun 25, 2026
| Starting Price | Not publicly listed (demo/quote-led) | Public free tier and documented higher tiers | Cloud costs passed through; enterprise pricing typically quote-led |
| Best For | Teams seeking a HIPAA-oriented bioinformatics platform that deploys in a customer cloud and offers orchestration and packaged apps | Organizations needing a trusted research environment/federated analysis model and clear plan structure | Cloud workflow execution with pass-through infrastructure billing; documented compute examples for specific workflows |
| Key Strength | Vendor-stated "runs in customers' clouds" posture and orchestration features | Public plan structure including a free tier and explicit TRE framing | Strong documentation around cloud infrastructure billing and workflow cost examples |
| Key Weakness | Limited public security certification disclosures and limited independent review footprint; pricing opacity | Some enterprise features require paid tiers; free tier has limitations | Cloud costs can remain a major component and users retain responsibility for cloud spend |
—
Where HypaHub's approach may be advantageous:
Where competitors may have advantages:
Build-it-yourself alternative:
Sources: